Melissa Mastroianni

She is a dual board-certified plastic surgeon by the America Board of Plastic Surgery and the American Board of Surgery. She completed two residencies, general and plastic surgery, and has a wide breadth of experience treating patients from head to toe. She has extensive training in plastic surgery and is proficient in microsurgery for breast reconstruction, limb salvage, craniofacial trauma and aesthetics. She is passionate about body transformation after massive weight loss and optimizing aesthetics of the breast after aging or breast cancer. She also developed an interest in emerging technologies in Plastic Surgery and she serves on the Emerging Trends Committee with the American Association of Plastic Surgeons so she can learn about cutting-edge technologies as they develop.

Dr. Mastroianni is from Milwaukee, Wisconsin and attended the University of Wisconsin- Madison for an undergraduate, where she earned a bachelor’s degree in Biochemistry with Honors in Research. She stayed at UW-Madison for medical school as well. Dr. Mastroianni began her general surgery residency in Rochester, New York. She pursued a research fellowship at the Massachusetts General Hospital performing cutting-edge research in hand and face transplantation. Following her fellowship, she transferred to the Brigham and Women’s Hospital in Boston to complete her general surgery training.

She completed Plastic and Reconstructive Surgery training at Johns Hopkins Hospital and the University of Maryland Combined Program in Baltimore. She developed a strong base of plastic surgery skills at these institutions. It was during her training that she developed a passion for microsurgery and personalized treatment of breast cancer patients to optimize aesthetics of reconstruction.

Dr. Mastroianni began her career as an Assistant Professor of Plastic Surgery at Yale University. She joins New York Bariatric Group to follow her passion to transform patients’ lives to help people feel at home in their own skin. She and her husband have two daughters and live in Connecticut where they enjoy nature hikes, playing at the beach and exploring the local restaurants.

Logo media

Melissa Mastroianni, MD Publications

Cutaneous leukocyte lineages in tolerant large animal and immunosuppressed clinical vascularized composite allograft recipients

Local Immunosuppression for Vascularized Composite Allografts: Application of Topical FK506- TyroSpheres in a Nonhuman Primate Model.

Proliferative Lesions Found at Reduction Mammaplasty

Skin grafts from genetically modified α-1,3-galactosyltransferase knockout miniature swine: A functional equivalent to allografts

Skin grafts from genetically modified α-1,3-galactosyltransferase knockout miniature swine: A functional equivalent to allografts

Topical Delivery of Immunosuppression to Prolong Xenogeneic and Allogeneic Split-Thickness Skin Graft Survival

Abstract 38. Atypical Proliferative Lesions after Reduction Mammaplasty

Nipple Loss following Nipple-Sparing Mastectomy

Assessment of Patient Factors, Surgeons, and Surgeon Teams in Immediate Implant-Based Breast Reconstruction Outcomes

Upper Extremity Transplantation in Non-Human Primates: An Orthotopic Model for Translational Research

Genetically modified porcine split-thickness skin grafts as an alternative to allograft for provision of temporary wound coverage: preliminary characterization

Impact of Surgeon and Surgical Team on Outcomes in Immediate Implant Based Breast Reconstruction

Impact of surgeon and surgical team on outcomes in immediate implant based breast reconstruction (IBR)

Initial Evidence for Functional Immune Modulation in Primate Recipients of Porcine Skin Grafts Following Conditioning With Human CD47 Transgenic Pig Hematopoietic Stem Cells.

Abstract P21 Topical Immunosuppression Does Not Prolong Xenogeneic Skin Graft Survival

Lower extremity soft tissue defect reconstruction with the serratus anterior flap

Concomitant Face/Upper Extremity Allotransplantation

Wnt signaling can substitute for estrogen to induce division of ERalpha-positive cells in a mouse mammary tumor model.